How it works
This blend pairs two tissue-repair peptides that act through separate pathways, which is the reason they are studied together. BPC-157, a synthetic pentadecapeptide derived from a gastric juice protein, is associated in the literature with angiogenesis and fibroblast migration. TB-500, a fragment of thymosin β-4, acts on actin sequestration and the cell migration that depends on it. Neither substitutes for the other: co-administration is documented in published animal repair models precisely because the mechanisms are complementary rather than overlapping. Component ratio is fixed; vials are not split at source.
BPC-157 10mg · TB-500 10mg
Learn more about the science →Certificate of Analysis+
Per-component LC-MS identity and HPLC purity, mass spec confirmation, endotoxin by LAL, appearance. Third-party ISO-17025 verified.
View full certificate →Specifications+
Storage & handling+
Lyophilized: −20°C, protected from light. Reconstituted: 2–8°C. Reconstitute with bacteriostatic water; swirl gently, do not shake.
We ship in insulated parcels with phase-change cooling and a tamper-evident seal.
FAQs+
Why are these two blended?+
Different mechanisms, complementary in repair models. BPC-157 acts on angiogenesis and fibroblast pathways; TB-500 on actin sequestration and cell migration. Co-administration is documented in the published animal literature.
Can the components be bought separately?+
Yes — both are stocked as individual SKUs. The blend is a single vial at a fixed ratio, not a bundle of two.
Is the ratio adjustable?+
No. Components are combined at source at 10mg each and vials are not split.
How is a blend verified?+
Per component. Each is confirmed by LC-MS identity and HPLC purity against its own theoretical mass, and both appear on the lot COA.
The research behind this compound, cited in full.
Provided for context only. None of the studies cited below evaluate hábit material specifically; they document the published literature on the compound and its mechanism. Research-use claims are not therapeutic claims.
- [01] Sikiric P. et al. Curr Pharm Des 20 (2014): 1126–1135.
- [02] Goldstein A.L. et al. Ann N Y Acad Sci 1112 (2007): 1–14.
Verified buyer notes
Initials only — every quote is verified against an order record. We don’t ghost-write reviews.
“COA matched what we ran in-house. Powder reconstituted clean, no haze. Did exactly what we needed it to.”
“Switched after two bad lots from a previous source. Three orders in, zero issues.”
“Asked support a purity question and got the raw HPLC trace back within the hour. That transparency is why we reorder.”